⚙
AI-generated deep summary
by claude@2026-07, 2026-07-16
· read from full text
ⓘ
This paper studied how optimized deep brain stimulation (DBS) in dystonia affects communication within the pallidothalamic network by analyzing intracranial neural signals recorded from 13 pediatric and young adult dystonia patients during DBS-on and DBS-off conditions. Using a novel transfer function approach, the authors compared signal transmission gains across deep brain pathways in low-frequency bands and found that GPi stimulation increased transfer function gains from the pallidum to thalamic motor subnuclei, particularly in the beta and gamma ranges. The authors interpret this as DBS decreasing inhibitory output from GPi to thalamus via enhanced high-frequency transmission, while noting that the broader mechanism of action is still not fully established and their inference is based on network signal transmission metrics. This paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.
Abstract
Deep brain stimulation (DBS) is a neuromodulation technique commonly used for treatment of movement disorders, including dystonia. Stimulation of the globus pallidus internus (GPi) of basal ganglia or the subthalamic nucleus (STN) typically confers clinical benefit, although the specific mechanism of action remains unclear. Previous studies in dystonic patients show abnormalities in low-frequency activity in GPi and other motor sensory regions such as STN, ventralis oralis anterior/posterior (VoaVop), and ventral anterior (VA) nuclei of thalamus. We hypothesize that DBS works in part by modulating transmission of abnormal signals in low frequency bands between different brain regions, both at the stimulation site (e.g. GPi) and distant deep brain regions. To test this hypothesis, we used a novel transfer function analysis that has not previously been utilized to study neural signal transmission. We recorded intracranial signals from 13 pediatric and young adult patients with dystonia, with and without stimulation. We performed transfer function analysis to compare the mean transfer function gain—representing signal amplification from input to output—across deep brain pathways in low-frequency bands, under both DBS-on and DBS-off conditions. Our results show that DBS modulates signal transmission between different brain regions. In particular, GPi stimulation increased transfer function gains from pallidum to thalamic motor subnuclei, especially in the beta and gamma frequency bands. These findings support the hypothesis that DBS decreases inhibitory output from GPi to thalamus through enhanced high-frequency transmission, offering insight into its mechanism of action. This, in turn, may provide fundamental knowledge for the development of closed-loop DBS, particularly in controlling the intensity and pattern of stimulation. A better understanding of neuromodulation could also help to further the design of brain-computer interfaces and neurorehabilitation systems.
Full text
4,140 characters
· extracted from
oa-doi-fallback
· click to expand
Abstract
Deep brain stimulation (DBS) is a neuromodulation technique commonly used for treatment of movement disorders, including dystonia. Stimulation of the globus pallidus internus (GPi) of basal ganglia or the subthalamic nucleus (STN) typically confers clinical benefit, although the specific mechanism of action remains unclear. Previous studies in dystonic patients show abnormalities in low-frequency activity in GPi and other motor sensory regions such as STN, ventralis oralis anterior/posterior (VoaVop), and ventral anterior (VA) nuclei of thalamus. We hypothesize that DBS works in part by modulating transmission of abnormal signals in low frequency bands between different brain regions, both at the stimulation site (e.g. GPi) and distant deep brain regions.
To test this hypothesis, we used a novel transfer function analysis that has not previously been utilized to study neural signal transmission. We recorded intracranial signals from 13 pediatric and young adult patients with dystonia, with and without stimulation. We performed transfer function analysis to compare the mean transfer function gain—representing signal amplification from input to output—across deep brain pathways in low-frequency bands, under both DBS-on and DBS-off conditions. Our results show that DBS modulates signal transmission between different brain regions. In particular, GPi stimulation increased transfer function gains from pallidum to thalamic motor subnuclei, especially in the beta and gamma frequency bands. These findings support the hypothesis that DBS decreases inhibitory output from GPi to thalamus through enhanced high-frequency transmission, offering insight into its mechanism of action. This, in turn, may provide fundamental knowledge for the development of closed-loop DBS, particularly in controlling the intensity and pattern of stimulation. A better understanding of neuromodulation could also help to further the design of brain-computer interfaces and neurorehabilitation systems.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Cerebral Palsy Alliance Research Foundation (PG02518)
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The institutional review board of Children's Health Orange County (CHOC) approved the research use of data and all the surgical procedures and clinical management took place at CHOC, in accordance with standard hospital procedures and policies. The institutional review board of Children's Hospital of Los Angeles (CHLA) approved the research use of data and all the surgical procedures and clinical management took place at CHOC, in accordance with standard hospital procedures and policies.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
kasirim{at}uci.edu
5 “Estimates” are the estimates of the effect sizes.
Data Availability
All data produced in the present study are available upon reasonable request to the authors. (Confidential data)
Text is read by the "Ask this paper" AI Q&A widget below.
Extraction quality varies by source — PMC NXML preserves structure
cleanly, OA-HTML may include some navigation residue, and OA-PDF can
have broken hyphenation. The publisher copy
(via DOI)
is the canonical version.